Obese pancreatic cancer surgical patients with a body mass index of more than 35 had a twelvefold higher risk of lymph node metastases and an almost doubled risk for cancer recurrence and death, compared with other patients, a study of 285 people found. Researchers said the findings indicate that obesity is a host factor influencing tumor biology.

Related Summaries